Biofrontera AG (NASDAQ:BFRA) went up by 12.70% from its latest closing price compared to the recent 1-year high of $9.80. The company’s stock price has collected -7.13% of loss in the last five trading sessions. Press Release reported on 11/19/21 that Biofrontera AG announces mediation results
Is It Worth Investing in Biofrontera AG (NASDAQ :BFRA) Right Now?
Plus, the 36-month beta value for BFRA is at 1.07. Opinions of the stock are interesting as 4 analysts out of 4 who provided ratings for Biofrontera AG declared the stock was a “buy,” while 0 rated the stock as “overweight,” 0 rated it as “hold,” and 0 as “sell.”
The average price from analysts is $15.20, which is $4.33 above the current price. BFRA currently public float of 13.16M and currently shorts hold a 0.00% ratio of that float. Today, the average trading volume of BFRA was 14.19K shares.
BFRA’s Market Performance
BFRA stocks went down by -7.13% for the week, with a monthly drop of -25.00% and a quarterly performance of -31.07%, while its annual performance rate touched -40.91%. The volatility ratio for the week stands at 11.04% while the volatility levels for the past 30 days are set at 7.23% for Biofrontera AG. The simple moving average for the period of the last 20 days is -14.38% for BFRA stocks with a simple moving average of -29.37% for the last 200 days.
Analysts’ Opinion of BFRA
The Benchmark Company, on the other hand, stated in their research note that they expect to see BFRA reach a price target of $8, previously predicting the price at $18. The rating they have provided for BFRA stocks is “Buy” according to the report published on April 20th, 2020.
The Benchmark Company gave a rating of “Buy” to BFRA, setting the target price at $18 in the report published on November 20th of the previous year.
BFRA Trading at -19.52% from the 50-Day Moving Average
After a stumble in the market that brought BFRA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -57.44% of loss for the given period.
Volatility was left at 7.23%, however, over the last 30 days, the volatility rate increased by 11.04%, as shares sank -23.26% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -18.71% lower at present.
During the last 5 trading sessions, BFRA fell by -7.13%, which changed the moving average for the period of 200-days by -51.68% in comparison to the 20-day moving average, which settled at $4.81. In addition, Biofrontera AG saw -42.37% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for BFRA
Current profitability levels for the company are sitting at:
- -18.49 for the present operating margin
- +71.07 for the gross margin
The net margin for Biofrontera AG stands at -42.92. The total capital return value is set at -17.39, while invested capital returns managed to touch -41.89. Equity return is now at value -88.90, with -22.80 for asset returns.
Based on Biofrontera AG (BFRA), the company’s capital structure generated 323.73 points at debt to equity in total, while total debt to capital is 76.40. Total debt to assets is 40.95, with long-term debt to equity ratio resting at 308.28. Finally, the long-term debt to capital ratio is 72.76.
When we switch over and look at the enterprise to sales, we see a ratio of 4.16, with the company’s debt to enterprise value settled at 0.14. The receivables turnover for the company is 7.11 and the total asset turnover is 0.51. The liquidity ratio also appears to be rather interesting for investors as it stands at 3.15.